Medroxyprogesterone acetate
Product #:
TL0583
Image
SKU-Pack Size
Stock
Price($)
Quantity
-
-
TL0583-1G
In stock
43.4
-
+
TL0583-5G
In stock
156.4
-
+
Details
l General Information |
Product Name | Medroxyprogesterone acetate |
General description | Medroxyprogesterone acetate is a synthetic progestin that is derived from 17-hydroxyprogesterone. |
Synonym | 17α-Hydroxy-6α-methyl-4-pregnene-3,20-dione 17-acetate; Medroxyprogesterone 17-acetate; NSC-26386; |
Purity | ≥99.0%(HPLC) | CAS Number | 71-58-9 |
Formula | C24H34O4 | Molecular Weight | 386.52 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥10mg/mL |
Ethanol | ≥10mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Medroxyprogesterone Acetate is a synthetic, acetate derivative of the sex hormone progesterone. Progestins diffuse freely into target cells in the female reproductive tract, mammary gland, hypothalamus, and the pituitary and bind to the progesterone receptor. Once bound to the receptor, progestins slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH surge. |
Application | 1. Antineoplastic Agents, Hormonal Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. 2. Contraceptive Agents, Male Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. 3. Contraceptive Agents, Female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. |
l Packaging & Storage |
Packaging | 1g; 5g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |